Tilray Brands (TLRY) Enterprise Value (QoQ) (2018 - 2026)
Tilray Brands (TLRY) Enterprise Value (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Tilray Brands | 519.72 Mn | 285.09 Mn | 90.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -0.95% |
| Feb 28, 2026 | 22.52% |
| Nov 30, 2025 | -14.02% |
| Aug 31, 2025 | -2.39% |
| Nov 30, 2024 | 1.15% |
| Aug 31, 2024 | -5.56% |
| May 31, 2024 | -7.69% |
| Feb 29, 2024 | -2.94% |
| Nov 30, 2023 | 46.96% |
| Aug 31, 2023 | -1.93% |
| May 31, 2023 | -7.18% |
| Feb 28, 2023 | 3.68% |
| Nov 30, 2022 | 7.10% |
| Aug 31, 2022 | -21.28% |
| May 31, 2022 | -52.11% |
| Feb 28, 2022 | 16.82% |
| Nov 30, 2021 | 4.82% |
| Aug 31, 2021 | 35.71% |
| Mar 31, 2020 | -58.71% |
| Dec 31, 2019 | 15.91% |